Tags Posts tagged with "ATHX"

ATHX

Athersys ATHX Stock News

0 3274
Athersys, Inc. (NASDAQ: ATHX) Athersys (ATHX) is an international biopharmaceutical company engaged in the discovery and development of therapies designed to extend and enhance the...
Athersys Inc ATHX Stock News

0 1445
Athersys, Inc. (NASDAQ: ATHX) Athersys is having an incredible day in the market today, and for good reason. Early this morning, the company released positive...
Athersys ATHX Stock News

0 2727
Athersys, Inc (NASDAQ: ATHX) Athersys is having an incredibly strong day in the market today, and for good reason. The company released data from a...
Athersys ATHX Stock News

0 2489
Athersys, Inc. (NASDAQ: ATHX) Athersys is having a great day in the market today after announcing that a partnership agreement has been signed with Healios....
Athersys ATHX stock news

0 2776
Athersys, Inc. (NASDAQ: ATHX) As expected Athersys recently reported their earnings for the first quarter. Unfortunately, the report wasn't what we expected to see. As...
Athersys ATHX stock news

1 3375
Athersys, Inc. (NASDAQ: ATHX) On Friday, ATHX fell hard after releasing phase II study of MultiStem cell therapy for treatment of ischemic stroke data. The...
Athersys ATHX stock news

0 2674
Athersys, Inc. (NASDAQ: ATHX) Athersys has a big day coming on the 19th. As mentioned in a previous post, the company will be releasing the...
Athersys ATHX stock news

1 2815
Athersys, Inc. (NASDAQ: ATHX) Athersys, Inc. stock recently climbed following an announcement that they would provide Phase 2 data from a new treatment on April...
Athersys ATHX stock news

0 3574
Athersys, Inc. (NASDAQ: ATHX) Athersys had an incredible day in the market yesterday; climbing by more than 10% on positive news. However, today the story...
Stocks Are Falling On Poor Economic Data

1 3709
US stocks are down overall today for the third day in a row today; with today's drop looking to be the steepest for many....

Thought Leader Discussions

Josh Disbrow head shot1 (1)

0 1502
Aytu Bioscience Inc (OTCMKTS: AYTU) Recently, the CNA Finance team had an opportunity to speak with Josh Disbrow, CEO of Aytu Bioscience. Josh Disbrow has...